Wave Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	544.59	602.07	302.08	200.35	88.5	150.56
Cash & Short-Term Investments	544.59	602.07	302.08	200.35	88.5	150.56
Cash Growth	124.04%	99.31%	50.77%	126.39%	-41.22%	-18.39%
Accounts Receivable	-	1.28	1.42	21.09	-	-
Other Current Assets	16.68	11.47	16.89	13.94	10.04	12
Total Current Assets	561.27	614.81	320.39	235.37	98.54	162.56
Net Property, Plant & Equipment	18.07	19.86	28	35.72	44.13	40.64
Other Long-Term Assets	4.2	3.82	3.82	3.86	3.72	3.8
Total Assets	583.54	638.5	352.21	274.95	146.39	207.01
Accounts Payable	19.06	15.7	16.26	12.84	16.92	7.28
Accrued Expenses	13.04	26.56	21.08	16.83	17.55	14.86
Current Portion of Leases	8.33	8.36	7.64	6.71	5.5	4.96
Unearned Revenue	9.4	44.44	65.97	150.06	31.56	37.1
Total Current Liabilities	49.83	95.07	110.95	186.44	71.52	64.2
Long-Term Leases	7.39	9.41	17.77	25.4	32.12	24.96
Other Long-Term Liabilities	14.6	7.8	6.1	15.6	79.96	77.48
Total Long-Term Liabilities	21.98	17.2	23.87	41.01	112.08	102.43
Total Liabilities	71.81	112.27	134.82	227.45	183.6	166.64
Common Stock	1,627	1,616	1,175	935.37	802.83	749.85
Additional Paid-in Capital	237.43	228.37	156.45	129.24	119.44	87.98
Accumulated Other Comprehensive Income	-0.25	-0.25	-0.26	-0.12	-0.03	0.18
Retained Earnings	-1,352	-1,326	-1,122	-1,025	-967.34	-805.51
Total Common Shareholders' Equity	511.73	518.36	209.52	39.63	-45.09	32.5
Minority Interest	-	7.87	7.87	7.87	7.87	7.87
Shareholders' Equity	511.73	526.23	217.39	47.5	-37.22	40.37
Total Liabilities & Equity	583.54	638.5	352.21	274.95	146.39	207.01
Total Debt	15.72	17.77	25.4	32.12	37.61	29.92
Net Cash (Debt)	528.88	584.3	276.67	168.23	50.88	120.65
Net Cash Growth	-9.49%	111.19%	64.46%	230.63%	-57.83%	-22.26%
Net Cash Per Share	2.97	3.46	2.00	1.59	0.65	2.33
Book Value	511.73	518.36	209.52	39.63	-45.09	32.5
Book Value Per Share	2.87	3.07	1.52	0.37	-0.57	0.63
Tangible Book Value	511.73	518.36	209.52	39.63	-45.09	32.5
Tangible Book Value Per Share	2.87	3.07	1.52	0.37	-0.57	0.63

SEC Filings: 10-K · 10-Q